Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

Poorly differentiated pancreatic neuroendocrine tumors (PDNEC), are a subtype of pancreatic cancer encompassing both small cell and large cell neuroendocrine carcinoma subtypes, and are characterized as distinct in terms of biology and prognosis compared to the more common pancreatic adenocarcinoma....

Descripción completa

Detalles Bibliográficos
Autores principales: Keane, Fergus, Bajwa, Raazi, Selenica, Pier, Park, Wungki, Roehrl, Michael H., Reis-Filho, Jorge S., Mandelker, Diana, O’Reilly, Eileen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122663/
https://www.ncbi.nlm.nih.gov/pubmed/37087482
http://dx.doi.org/10.1038/s41698-023-00376-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122663/
https://www.ncbi.nlm.nih.gov/pubmed/37087482
http://dx.doi.org/10.1038/s41698-023-00376-x

Ejemplares similares